Medication info
Newcozal Tablet 5/50 mg (Amlodipine, Losartan Potassium)

Newcozal Tablet 5/50 mg (Amlodipine, Losartan Potassium)

Prescription medicationTabletOral
Ingredient · strength
Amlodipine Besylate›6.944mg / 1 tabletLosartan Potassium›50mg / 1 tablet
Manufacturer / importer
Dasan Pharmaceutical Co., Ltd.
Appearance
White rectangular film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 201903732 · Approved 2019.06.04

Summary

Main use
Treatment of essential hypertension inadequately controlled with monotherapy and stage 2 hypertension
Who takes it
Adults · Children
Adult dose
The recommended dose is 1 tablet once daily, taken with water, with or without food. It is recommended to take the medicine at the same time each day, if possible (e.g., in the morning). Before administering this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or losartan). However, if blood pressure is not controlled with monotherapy using the individual components, switching directly to this medicine may be considered as follows: - 5/50 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or losartan 50 milligrams as monotherapy. - 5/100 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or losartan 100 milligrams as monotherapy. Patients taking amlodipine and losartan concomitantly may be switched to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Before administering this medicine as initial therapy to patients with stage 2 hypertension, the decision to treat should take into account baseline blood pressure, target blood pressure, and the expected likelihood of reaching the treatment goal with the combination product compared with monotherapy. The usual dose is 5/50 milligrams once daily; if blood pressure is not adequately controlled after 2 weeks of treatment, the dose may be increased to 10/50 milligrams once daily. ○ Patients with renal impairment: No dosage adjustment is required in patients with mild renal impairment (e.g., creatinine clearance 20∼50 mL/min); however, use of this medicine is not recommended in patients with moderate to severe renal impairment (e.g., creatinine clearance < 20 mL/min) or in patients undergoing dialysis. ○ Patients with reduced intravascular volume: Use of this medicine is not recommended in a small number of patients with reduced intravascular volume (e.g., patients receiving high doses of diuretics). (See section 1, Warnings, under Precautions for Use.) ○ Patients with hepatic impairment: Use of this medicine is not recommended in patients with a history of hepatic impairment who require a reduced dose of losartan (e.g., 25 milligrams once daily). ○ Elderly patients: In patients 75 years of age or older, an initial dose of losartan of 25 milligrams once daily is recommended; therefore, use of this medicine as initial treatment is not recommended.
Child dose
○ Children: The safety and efficacy of this medicine have not been established in pediatric patients 18 years of age or younger; therefore, administration is not recommended.

Ingredients

Manufacturer
Dasan Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension inadequately controlled with monotherapy and stage 2 hypertension

  • Essential hypertension
  • Stage 2 hypertension
View approved original text

This medication is used for patients with essential hypertension who do not achieve adequate blood pressure control with monotherapy of amlodipine or losartan. It is also used as a first-line therapy for patients with Stage 2 hypertension who require combination therapy to reach the target blood pressure. Therefore, it effectively assists in blood pressure control and improves hypertension management.

How to take

Adult dose

The recommended dose is 1 tablet once daily, taken with water, with or without food. It is recommended to take the medicine at the same time each day, if possible (e.g., in the morning). Before administering this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or losartan). However, if blood pressure is not controlled with monotherapy using the individual components, switching directly to this medicine may be considered as follows: - 5/50 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or losartan 50 milligrams as monotherapy. - 5/100 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or losartan 100 milligrams as monotherapy. Patients taking amlodipine and losartan concomitantly may be switched to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Before administering this medicine as initial therapy to patients with stage 2 hypertension, the decision to treat should take into account baseline blood pressure, target blood pressure, and the expected likelihood of reaching the treatment goal with the combination product compared with monotherapy. The usual dose is 5/50 milligrams once daily; if blood pressure is not adequately controlled after 2 weeks of treatment, the dose may be increased to 10/50 milligrams once daily. ○ Patients with renal impairment: No dosage adjustment is required in patients with mild renal impairment (e.g., creatinine clearance 20∼50 mL/min); however, use of this medicine is not recommended in patients with moderate to severe renal impairment (e.g., creatinine clearance < 20 mL/min) or in patients undergoing dialysis. ○ Patients with reduced intravascular volume: Use of this medicine is not recommended in a small number of patients with reduced intravascular volume (e.g., patients receiving high doses of diuretics). (See section 1, Warnings, under Precautions for Use.) ○ Patients with hepatic impairment: Use of this medicine is not recommended in patients with a history of hepatic impairment who require a reduced dose of losartan (e.g., 25 milligrams once daily). ○ Elderly patients: In patients 75 years of age or older, an initial dose of losartan of 25 milligrams once daily is recommended; therefore, use of this medicine as initial treatment is not recommended.

Child dose

○ Children: The safety and efficacy of this medicine have not been established in pediatric patients 18 years of age or younger; therefore, administration is not recommended.

Precautions

This medication can cause serious harm to the fetus, especially during the second and third trimesters of pregnancy, and should be discontinued immediately if pregnancy is confirmed. Women of childbearing potential are advised not to take this medication. It is also considered unsafe during breastfeeding. Patients with reduced intravascular effective blood volume, such as those taking diuretics, may experience hypotension upon initial administration of this medication, and caution is required. Patients allergic to this medication's active ingredients or similar components should not take it. Patients with severe hepatic impairment, severe aortic stenosis, or in shock should not use this medication. As blood pressure may drop, it is advisable to avoid dangerous activities such as high-altitude work or driving. Side effects such as dizziness, headaches, drowsiness, dyspepsia, and skin rashes may occur during the use of this medication; if unusual symptoms arise, consult a doctor. When used in conjunction with other blood pressure medications, the effects may be amplified, so it should strictly be taken according to the doctor's instructions. Grapefruit juice may enhance the effects of this medication; hence, it should be avoided. Elderly patients or those with impaired kidney function may require dose adjustment, so consultation with a physician is needed. Overdose may lead to severe hypotension or cardiac issues, so it is essential to adhere to the exact dosage. This medication is not recommended for children due to uncertain safety and efficacy. Regular testing may be needed as liver or kidney function may change during treatment. Store the medication out of reach of children, and it is best not to transfer it to another container.

Side effects

  • Dizziness
  • headache
  • drowsiness
  • cerebrovascular accident
  • weakness
  • chest discomfort
  • chest pain
  • early satiety
  • peripheral edema
  • pitting edema
Show 172 more
  • abdominal discomfort
  • dyspepsia
  • nausea
  • gastroesophageal reflux disease
  • constipation
  • pruritus
  • urticaria
  • palpitations
  • flushing
  • orthostatic hypotension
  • facial flushing
  • dyspnea
  • cough
  • conjunctival injection
  • increased urination
  • fatigue
  • edema
  • vasculitis
  • hypertonia
  • sensory loss
  • dysesthesia
  • peripheral neuropathy
  • syncope
  • dysgeusia
  • tremor
  • erectile dysfunction
  • gynecomastia
  • changes in bowel habits
  • dry mouth
  • gastritis
  • gingival hyperplasia
  • pancreatitis
  • vomiting
  • hyperglycemia
  • arthralgia
  • low back pain
  • muscle cramps
  • myalgia
  • leukopenia
  • thrombocytopenia
  • insomnia
  • mood changes
  • rhinitis
  • hair loss
  • increased sweating
  • purpura
  • skin discoloration
  • toxic epidermal necrolysis
  • tinnitus
  • visual disturbance
  • increased frequency of urination
  • voiding difficulties
  • nocturia
  • hepatitis
  • jaundice
  • elevated liver enzymes
  • pruritus
  • rash
  • angioedema
  • erythema multiforme
  • myocardial infarction
  • arrhythmia
  • sinoatrial block
  • atrioventricular block
  • abdominal discomfort
  • precordial pain
  • diarrhea
  • loose stools
  • erythema nodosum
  • papular rash
  • heaviness
  • warmth
  • impaired glucose tolerance
  • weakness
  • muscle cramps
  • low back pain
  • leg pain
  • congestion
  • upper respiratory tract infection
  • sinusitis
  • diarrhea
  • sinus dysfunction
  • pharyngitis
  • myalgia
  • insomnia
  • edema
  • abdominal pain
  • angioedema
  • skin peeling
  • hemolysis
  • facial edema
  • fever
  • orthostatic effects
  • angina pectoris
  • second-degree atrioventricular block
  • cerebrovascular accident
  • hypotension
  • atrial fibrillation
  • bradycardia
  • tachycardia
  • ventricular tachycardia
  • ventricular fibrillation
  • appetite loss
  • toothache
  • flatulence
  • gastritis
  • anemia
  • gout
  • upper limb pain
  • hip pain
  • joint swelling
  • knee pain
  • musculoskeletal pain
  • shoulder pain
  • muscle rigidity
  • arthralgia
  • arthritis
  • fibromyalgia
  • muscle weakness
  • anxiety
  • anxiety disorder
  • ataxia
  • confusion
  • depression
  • nightmares
  • sensory decrease
  • decreased libido
  • memory impairment
  • migraine
  • neuralgia
  • panic disorder
  • sleep disorder
  • bronchitis
  • pharyngeal discomfort
  • epistaxis
  • respiratory congestion
  • dermatitis
  • skin dryness
  • petechial hemorrhage
  • erythema
  • photophobia
  • rash
  • sweating
  • blurred vision
  • burning sensation and pain in the eyes
  • conjunctivitis
  • taste distortion
  • tinnitus
  • visual impairment
  • nocturia
  • urethral infection
  • ALT elevation
  • syncope
  • loss of consciousness
  • acute hepatitis
  • fulminant hepatitis
  • anaphylactic syndrome
  • hypotension
  • shock symptoms
  • angioedema
  • vasculitis
  • anaphylactic reaction
  • intestinal vascular edema
  • lethargy
  • anemia
  • thrombocytopenia
  • rhabdomyolysis
  • dysgeusia
  • dry cough
  • erythroderma
  • hyperkalemia
  • hyponatremia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent air and moisture from entering and maintained at room temperature between 1 and 30 degrees. Proper storage ensures prolonged effectiveness of the medication.

Appearance and packaging

Appearance

White rectangular film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.